Intravenous cyclophosphamide for lupus nephritis in Thai children

Scandinavian Journal of Rheumatology

Volumn 33, Issue 5, 2004, Pages 339-342

  Vachvanichsanong, P ^a   Dissaneewate, P ^a   Winn, T ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CREATININE; CYCLOPHOSPHAMIDE; HEMOGLOBIN; INSULIN; ORAL ANTIDIABETIC AGENT; PREDNISONE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ALOPECIA; AMENORRHEA; ANALYSIS OF VARIANCE; ARTICLE; BLOOD CELL COUNT; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMORRHAGIC CYSTITIS; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KAPLAN MEIER METHOD; KIDNEY FUNCTION; LEUKOCYTE COUNT; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MALIGNANT NEOPLASTIC DISEASE; NAUSEA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SCHOOL CHILD; SKIN INFECTION; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THAILAND; THROMBOCYTOPENIA; VOMITING;

CHILD; CREATININE; CYCLOPHOSPHAMIDE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, ACUTE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PATIENT SELECTION; PROTEINURIA; SURVIVAL ANALYSIS; THAILAND;

EID: 7044223120     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740410006448     Document Type: Article

References (12)

1. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995;34:866-72.
2. Lehman TJ, Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 2000;36:243-7.
3. Eiser AR, Grishman E, Dreznin S. Intravenous pulse cyclophosphamide in the treatment of type IV lupus nephritis. Clin Nephrol 1993;40:155-9.
4. Boumpas DT, Austin HA 3rd, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992;340:741-5.
5. Gourley MF, Austin HA 3rd, Scott D, Yarboro CH, Vaughan EM, Muir J, et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 1996;125:549-57.
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
7. Felson DT, Anderson J. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis. N Engl J Med 1984;311:1528-33.
8. Valeri A, Radhakrishnan J, Estes D, D'Agati V, Kopelman R, Pernis A, et al. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study. Clin Nephrol 1994;42:71-8.
9. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996;7:924-9.
10. Lehman TJ, Sherry DD, Wagner-Weiner L, McCurdy DK, Emery HM, Magilavy DB, et al. Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediatr 1989;114:1055-60.
11. Balow JE, Austin HA 3rd, Tsokos GC, Antonovych TT, Steinberg AD, Klippel JH. NIH conference. Lupus nephritis. Ann Intern Med 1987;106:79-94.
12. Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, et al. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. Clin Nephrol 1996;46:170-5.